ロード中...
Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506?
The drugs cyclosporine A (CsA) and tacrolimus (FK506) revolutionized organ transplantation. Both compounds are still widely used in the clinic as well as for basic research, even though they have dramatic side effects and modulate other pathways than calcineurin-NFATc, too. To answer the major open...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2774854/ https://ncbi.nlm.nih.gov/pubmed/19860902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1478-811X-7-25 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|